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Abstract: Over the last decade, biology and biotechnology have witnessed an extraordinary development spanning
genomics, proteomics, and metabolics. This progress was so rapid and definite that it not only changed the face
of modern biology, but indeed altered the way day-to-day business is done in biology and related fields. This
scientific advancement came with a need for concurrent technological advances. In this context, the ability to
interface sophisticated devices with relevant biological microenvironments has emerged as a critical challenge.
Already, novel biomaterials are on the horizon that promise to fulfill the rigid criteria of being both biocompatible
under the conditions of a versatile range of biological applications and compatible with the increasing demands for
miniaturization, integration, and throughput of future device architectures. As currently employed solvent-based
polymer coatings are increasingly reaching their limits, a range of unconventional materials, such as vapor-based
polymer coatings, are discussed as attractive alternatives. One of the main features of vapor-based polyreactions
is their versatility in synthesizing both simple and complex polymers with relative ease and at generally low
temperatures. The advantages of the chemical vapor deposition (CVD) technique also include control of the
composition and architecture of the resulting materials, high accuracy, solvent-free environments, excellent
adhesion, and the ability to accommodate custom-tailored surface modifications. For further illustration, selected
examples of polymer-based surface engineering approaches using vapor-based polyreactions are discussed in this
review. For instance, reactive coating technology uses CVD polymerization to deposit a wide range of chemically
functionalized polymer coatings on various substrate materials. Its simplicity in providing chemically reactive
groups and its applicability to three-dimensional geometries (e.g. for microfluidics) enables exact tailoring
of surface properties and the preparation of biologically relevant microenvironments. CVD-based reactive
coatings are compatible with soft lithographic processes allowing for patterning of proteins, DNA, cytokines,
and mammalian cells.
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VAPOR-BASED SURFACE MODIFICATION
METHODS
Over the last few decades, a heterogeneous range
of methods has been developed to deposit coatings
from the vapor phase including laser-based processes,1
plasma2–4 and hot filament5 polymerization, as well
as chemical vapor deposition (CVD) polymerization.6
Similarly as heterogeneous as the spectrum of coat-
ing methods that have been employed, is the range
of applications that have been met in biomedi-
cal settings. For instance, a research group at the
University of Washington has used radio frequency
plasma deposited tetraglyme to create surface coatings
that resist protein adsorption and monocyte adhesion
in vitro.7,8 Similarly, Gleason and co-workers used hot
filament9,10 and plasma polymerization11,12 to cre-
ate functional materials coatings. Moreover, vapor
deposition has been shown to be applicable to an
astonishingly wide range of polyreactions and polymer
types. Li et al. reported the free radical polymerization
of vinyl monomers resulting in polystyrene, polyacry-
lamide, or poly(N-isopropylacrylamide) using cova-
lently attached initiators,13 while Yasutake et al. used
a pre-adsorbed initiator to prepare methyl methacry-
late/styrene block copolymers.14 The Frank group15–17
and, later, Wang and Chang18–21 reported the synthe-
sis of polypeptides through the vapor-based polyad-
dition of N-carboxy anhydrides. Tsukagoshi et al.
prepared thin polyamide films via alternate pulsed
vapor-based polycondensation of terephthaloylchlo-
ride and 4, 4′-diaminodiphenyl ether,22 while Fu
et al. reported on both the ring opening metathe-
sis polymerization and the cationic polymerization
of a range of different monomers.23 Vapor-based
processes have also been used for the deposition
of poly(p-phenylene vinylene),24–26 polydiacetylene,27
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poly(vinylidene fluoride),28 or polysiloxane coatings,
to name only a few examples.29 It is obvious from these
examples that CVD – already well established for the
formation of inorganic layers – has received increasing
attention for the deposition of polymer coatings. The
main feature of CVD polymerization is its versatil-
ity in synthesizing both simple and complex polymers
with relative ease and at generally low temperatures.
Further advantages of CVD-based polymer deposition
methods often include tight control over film compo-
sition, high coating fidelity, the use of solvent-free
processes, as well as excellent adhesion properties.
A major focus of this review is on vapor deposition
of poly(p-xylylene)s30 via free radical polymerization





In spite of the wide range of polyreactions that
have been conducted from the vapor phase, the
free radical polymerization of [2.2]paracyclophanes
to yield poly(p-xylylene)s remains among the best
established vapor-based polymerization technolo-
gies available today (Scheme 1). Non-functionalized
poly(p-xylylene) coatings, originally developed by
Gorham at Union Carbide, have been commercialized
under the parylene brand, which includes parylene
N, parylene C, and parylene D. Although poly(p-
xylylene)s can be prepared by various methods, includ-
ing electrochemical deposition,31 CVD polymerization
of [2.2]paracyclophanes has been most widely used
for the preparation of thin-film coatings (the so-
called Gorham process).32 The structural situation in
[2.2]paracyclophanes enables the thermal activation
of the ring structure by vacuum pyrolysis; ideally with-
out compromising the chemical backbone structure or
side groups. The CVD polymerization of [2.2]para-
cyclophanes tracing back to the pioneering work of
Gorham32 has since resulted in a wide range of applica-
tions, such as the use in stents,33 cardic pacemakers34
and defibrillators,35 neuronal probes,36 orthoden-
tic devices,37 or for BioMEMS applications.38,39 In
a very interesting extension of these technological
applications, Zeng et al. demonstrated the use of
poly(p-xylylene) coatings to modulate release kinetics
Scheme 1. Flow diagram of the Gorham process used for CVD
polymerization. [2.2]Paracyclophanes are sublimed (1), transported
into the pyrolysis zone (2), and deposited (3).
of a drug incorporated into an underlying porous
structure.40
Although commercially available non-functionalized
parylene coatings have been used in the biomedi-
cal community for a range of applications, they still
lack anchor groups for further modification and there-
fore fail as effective carriers for biomolecules. For
this reason, several approaches have been recently
developed to modify the surface properties of poly(p-
xylylene) coatings, such as plasma etching41,42 or wet
chemical modification via sulfonation, aminomethy-
lation, or amidomethylation.43 Given the interest in
surface-modified poly(p-xylylene)s, there is a clear
need for intrinsically reactive vapor-deposited polymer
coatings.
CVD POLYMERIZATION OF SUBSTITUTED
[2.2]PARACYCLOPHANES: REACTIVE POLYMER
COATINGS
In recent years there has been a number of
attempts to expand the Gorham process to a wider
range of custom-tailored poly(p-xylylene)s, such as
poly(octafluoro-p-xylylene).44 Although these coatings
still do not have reactive functional groups for further
surface modification, they may be of interest due
to their outstanding optical properties. Moreover,
a broad range of functionalized poly(p-xylylene)s
has been prepared that have functional groups with
sufficient reactivity to act as anchors for further surface
engineering (Scheme 2).45 These polymers often show
all the advantages of their commercial siblings, but,
in addition, provide a controlled platform for further
surface modifications.46,47 In essence, this technology
represents a one-step coating procedure to generate
functionalized surfaces on a wide range of substrate
materials and geometries48 – without requiring post-
treatment once the films are deposited.49
Although α,α′-dihydroxy-p-xylylenes,50,51 α,α′-
dibromo-p-xylylenes,52 α-chloro-p-xylylenes,53 and
α,α′-diacetoxy-p-xylylenes54 provide potential candi-
dates for functionalized poly(p-xylylene)s as they
all have been shown to undergo CVD polymer-
ization, substituted [2.2]paracyclophanes have been
the preferred precursors for CVD polymerization – at
least in our hands.55 Scheme 2 summarizes the
synthesis of [2.2]paracyclophanes with various func-
tional groups. When synthesizing mono- or di-
substituted [2.2]paracyclophanes, the entry step is
often a Friedel–Crafts acylization of the commercially
available [2.2]paracyclophane. The resulting ketones
can be used as they are, or modified by hydrol-
ysis to yield 4-carboxy[2.2]paracyclophane and its
derivatives. Other interesting polymers for biomed-
ical applications include amino-substituted poly(p-
xylylene)s. However, their preparation by CVD had
been limited by the lack of facile and effective syn-
theses of amino-functionalized [2.2]paracyclophanes.
4-Amino[2.2]paracyclophane has been synthesized
using a multistep approach via [2.2]paracyclophane
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Scheme 2. CVD polymerization of substituted [2.2]paracyclophanes to yield a wide range of different poly(p-xylylene)s.
carboxylic as a key intermediate.56 Alternatively, treat-
ment of [2.2]paracyclophane with nitronium ions,57
which exhibit high nitration power even at low tem-
peratures, will yield 4-nitro[2.2]paracyclophane. The
latter can be reduced to the corresponding amine.58
Alternatively, [2.2]paracyclophane can also be con-
verted to the corresponding ethinyl derivative in a
two-step reaction.59 Higher substituted [2.2]paracy-
clophanes, such as poly(p-xylylene) anhydride, are
also suitable for CVD polymerization, but their syn-
thesis is often more involved. In this case, 4,5,12,13-
tetrakis(methyloxycarbonyl)[2.2]paracyclophane is
the key intermediate, which can be synthesized by
Diels–Alder reaction of acetylenedicarboxylic acid
dimethyl ester with hexatetraene.49 The hexatetraene
is accessible by conversion of propargylic bromide
with the Grignard compound allenylic magnesium
bromide (Scheme 3). Dehydratization of 4,5,12,13-
tetrakis(methyloxycarbonyl)[2.2]paracyclophane with
concentrated sulfuric acid resulted in [2.2]paracyclo-
phane-4,5,12,13-tetracarboxylic acid dianhydride.
[2.2]Paracyclophane-4,5,12,13-tetracarboxylic γ -but-
yryl lactone can be synthesized from the anhydride by

















Scheme 3. Synthesis of mono-substituted [2.2]paracyclophanes as
versatile precursors for CVD polymerization.
Once the substituted [2.2]paracyclophanes are
synthesized, the subsequent CVD polymerization
is a room temperature deposition process, which
does not involve catalysts, solvents, or initiators.
In the CVD process, the starting material, a sub-
stituted [2.2]paracyclophane, is sublimed and sub-
sequently transferred into the pyrolysis zone. The
[2.2]paracyclophanes comprise dimers, which can be
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symmetric or asymmetric, resulting in polymers or
copolymers, respectively. Polymerization parameters
must be selected to ensure cleavage of the C–C
single bonds resulting in the corresponding quin-
odimethanes. Subsequently, the monomer is trans-
ferred to a cooler deposition chamber, typically at or
below room temperature, where spontaneous poly-
merization occurs. CVD polymerization of [2.2]para-
cyclophanes requires simultaneous control of multiple
polymerization parameters. For most of the [2.2]para-
cyclophanes studied so far, we identified parameter
sets, which can be used to create high-quality polymer
films. A reaction system used for CVD polymerization
is shown in Fig. 1 and essentially consists of a subli-
mation zone, a pyrolysis zone, and a deposition zone.
The CVD installation must provide flexible control
of polymerization parameters, as well as monitoring
capability to record critical polymerization parameters.
We use a custom-designed CVD polymerization for
this purpose (Fig. 1).60 CVD polymerization requires
base pressures of around 5 × 10−5 bar and working
pressures (i.e. the pressure during polymerization) of
about 0.05 to 0.6 mbar depending on the choice of
[2.2]paracyclophane. The butterfly valve is located
at the downstream part of the equipment, while the
carrier gas inlet and flow control are both placed
upstream. This allows one to control the working
pressure within a flexible range of gas flows and also
prevents sudden pressure fluctuations due to subli-
mation of the precursor. The mechanical pump easily
accommodates working pressures below 0.08 mbar at
a mass flow of 10 sccm and 0.2 mbar at a mass flow of
20 sccm. Well-defined and usually chemically robust
polymer films can be prepared under these conditions
(Scheme 4). The adhesion of the CVD coatings can
be assessed using a simple peel test. For instance,
poly(4-formyl-p-xylylene-co-p-xylylene) was analyzed
by pressing scotch tape onto the polymer coating and
then peeling it off. Subsequent visual examination
showed the intactness of the film and infrared spectral
analysis confirmed the presence of the film (Fig. 2).
BIOACTIVE SURFACES BASED ON REACTIVE
COATINGS
Reactive CVD coatings offer a wide range of
chemical signatures and can be designed to support
immobilization of a variety of different biomolecules
including proteins61 and sugars.62 In a typical
surface engineering pathway, CVD polymerization
is used to create anchor groups on the surface of
the substrate. In a consecutive step, the protein
is brought into contact with the reactive CVD
coating and spontaneously tethers to the surface
via covalent bond formation. In some cases, the
orientation of the protein is highly critical and
an unfavorable orientation may result in loss of
biological activity of the protein. In a series of
experiments, we immobilized r-hirudin, the strongest
known thrombin inhibitor, to the surface of a
prospective biomaterial.63 A typical approach to
immobilize proteins is through their primary amino
groups, which can be reacted with activated groups
on a surface. In case of r-hirudin, the N-terminal
amino acid residues were found to be in a position
essential to its thrombin activity.64,65 When pursuing
this approach, the following dilemma arose: while
the N-terminal amino group has a superior chemical
reactivity compared to the remaining three lysine
ε-amino groups,66 its free availability is critical for
r-hirudin’s thrombin inhibition capacity. Therefore,
an indirect immobilization strategy was chosen using
an N-terminally protected r-hirudin derivative for
immobilization (Scheme 5). Deprotection of the
surface bound r-hirudin derivatives and intensive
Figure 1. Digital image of a CVD installation that is used to prepare reactive coatings based on functionalized poly(p-xylylene)s.
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Scheme 4. Synthesis of substituted [2.2]paracyclophanes.
Figure 2. Adhesion test routinely used in the author’s laboratory for reactive coatings; shown for poly(4-formyl-p-xylylene-co-p-xylylene).62
rinsing with sodium dodecyl sulfate-containing buffer
delivers surfaces with covalently bound active r-
hirudin. Bivalent hexamethylene diisocyanate linkers
were used for immobilization. In the case of poly(p-
xylylene-2,3-dicarboxylic acid anhydride), however,
the reactivity of the anhydride group was sufficient
for a direct linkage of (MSC)-r-hirudin without
further introduction of spacer moieties.60 The activity
of surface-bound r-hirudin towards thrombin was
determined using a thrombin time assay. Surfaces
prepared by covalent linkage of r-hirudin show strongly
enhanced prolongation of blood clotting due to
inactivation of thrombin by surface-bound r-hirudin.
These concepts are not only applicable to r-hirudin,
but may be extended to other proteins of similar
structure or function. After all, the choice of a specific
immobilization strategy needs to be decided on a
case-to-case basis.
Polym Int 55:1361–1370 (2006) 1365
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Although less common, the aldehyde functionality
exemplifies another candidate group useful for surface
modification, because of its high specificity towards
functional groups such as hydrazide, hydroxylamino,
and thiosemicarbazide groups.67 Several strategies
have been reported to generate aldehyde groups on a
variety of surfaces, such as glass, silicon, and metal
surfaces. These processes involve either multistep
chemistries or plasma polymerization of aldehyde-
containing monomers.68–71 However, a substrate-
independent procedure, such as CVD polymerization,





































Scheme 5. Immobilization of r-hirudin following an indirect
immobilization strategy consisting of (1) selective protection,
(2) immobilization, and (3) deprotection.
In a recent communication, we reported the
CVD polymerization of 4-formyl[2,2]paracyclophane
to yield an aldehyde-functionalized poly(p-xylylene),
poly(4-formyl-p-xylylene-co-p-xylylene), which is suit-
able for the immobilization of polysaccharides
(Scheme 6).62 The precursor 4-formyl[2,2]paracyclo-
phane can be synthesized via a two-step synthesis from
[2.2]paracyclophane. The resulting CVD coating was
insoluble in aqueous solutions as well as in a variety
of standard organic solvents such as ethanol, acetone,
methanol, dichloromethane, chloroform, dimethylfor-
mamide, and toluene. The insolubility in organic
solvents distinguishes the polymer films from start-
ing material and suggests that high-molecular weight
polymers are formed under the conditions of CVD
polymerization.
The availability and reactivity of the aldehyde groups
on poly(4-formyl-p-xylylene-co-p-xylylene) was stud-
ied using hydrazone formation.62 Using microcontact
printing (µCP), the condensation reaction between
the aldehyde groups on the surface and a biotinyl
hydrazide was performed (Fig. 3). After immobi-
lization, homogeneous and reproducible patterns of
sugar/lectin pairs were observed on the reactive coat-
ing, thus showing that the aldehyde groups on the
surface are reactive and can be used as anchoring
sites.
We further fabricated protein-resistant surfaces
based on vapor deposition of a photodefinable
coating, poly(4-benzoyl-p-xylylene-co-p-xylylene), on
the luminal surface of a microfluidic device followed by
a photopatterning step (Fig. 4).72 Due to its structural
analogy to benzophenone, this photoreactive coating
can be activated at wavelengths of about 340 nm. The
temporarily generated free radicals at the carbonyl
position spontaneously react with adjunct molecules,
mainly via C–H abstraction, and are crosslinked to the
surface.73 Based on this method, spatially controlled
confinement of non-fouling molecules, specifically
poly(ethylene oxide)s (PEOs), can be achieved.74 Prior
to photopatterning, the reactive coating is exposed to
an aqueous solution of PEO. A photomask is then
brought in close proximity to the surface and the CVD
polymer linker disaccharide
Scheme 6. Immobilization of a disaccharide to an aldehyde-reactive CVD coating.
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Figure 3. Fluorescence image of TRITC-labeled streptavidin conjugated to biotin-based ligands, which were patterned onto the reactive coating
using µCP.62
Figure 4. Schematic representation of the photopatterning method based on CVD polymerization of a photoreactive coating followed by
subsequent photolithography.72
coating is illuminated through the mask. The CVD
film essentially acts as a reactive photoresist and binds
the PEO molecules only in those areas exposed to the
light.75 To verify the bioinert properties of the surfaces
after covalent tethering of the PEO, we incubated
the entire sample surface with fluorescence-labeled
model proteins including fibrinogen and albumin.
Both proteins selectively adsorbed only to areas that
Polym Int 55:1361–1370 (2006) 1367
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corresponded to non-modified surfaces, while areas
that were modified with PEO showed very low
levels of protein adsorption, as concluded from the
fluorescence micrographs. The patterning quality was
limited by the spatial resolution of the photomask and
the distance of the photomask from the surface, i.e.
the depth of the microchannel.
To explore a biologically relevant system with
dimensions on the micrometer scale, interactions
of patterned surfaces with endothelial cells were
studied.76 In this study, we essentially established a
platform that allows spatially defined self-assembly
of antibodies that bind to features expressed on a
cell surface. This platform was used to guide cells
to defined locations on the substrate. It is well
known that cell adhesion is a specific process that
involves interactions between cell adhesion mediators
and cell surface receptors. For spatial control of
cell attachment, a sequence of steps was conducted:
(1) application of the reactive coating, (2) µCP of
amino-derived biotin ligands, and (3) layer-by-layer
self-assembly on patterned surfaces. A basic scheme
is shown in Fig. 5. Since the first step involves the
coating of the surface, the procedure is independent of
the substrate material. Potential biological applications
are discussed in the following section.
POTENTIAL APPLICATIONS RELATED TO
BIO-ANALYTICAL SYSTEMS
Miniaturized cell assays are of interest in the evalua-
tion of pharmacologically active molecules including
molecules that affect cell proliferation and adhesion.
In this context, the ability to create cell patterns may
be useful for advanced biological applications. For
instance, we used CVD-based surface engineering
methods to confine endothelial cells on the luminal
surface of a microchannel and studied the in vitro
activity of echistatin, a potent disintegrin and cell
adhesion inhibitor. For this purpose, immobilization
of an antibody that specifically captures α5-integrin to
a biotin-modified, CVD-coated microdevice was used
to confine endothelial cells inside the microfluidic
system. Suspensions of endothelial cells containing
various concentrations of echistatin were then per-
fused into the microchannels presenting α5-integrin-
capturing antibodies. This setup allowed for mon-
itoring the dose-dependent activity of echistatin by
determining the number of attached endothelial cells
(Fig. 6). For higher concentrations of the disintegrin,
the inhibition of cell adhesion was higher on the
antibody-coated surfaces than on the reference sur-
faces, revealing a higher selectivity with which cells
bind to the antibody-coated surfaces (Fig. 7). These
results provide the first evidence of the applicability
of the systems described above as cell-based biosen-
sors for chemical or biological agents77 or microfluidic
assays.76,78
CONCLUSIONS
CVD polymerization of functionalized [2.2]paracy-
clophanes establishes a general but simple protocol
for the preparation of polymer films. Applicability
of the reactive coating to various substrates, such as
polymers, metals, or composites,58 generates a fairly
universal platform without relying on broad chemical
alteration of the bulk material. The reactive coat-
ings have anchor groups with reactivity patterns that











































Figure 5. Schematic representation of the surface modification that lead to a microdevice with a biologically active surface. The device is first
modified with a reactive coating, which is then used to bind biotin ligands and streptavidin. A biotin-labeled antibody is then bound to the modified
PDMS surface and used to study cell surface receptor activity. Corner: fluorescence-labeled streptavidin bound in the microchannel.76
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Figure 6. Schematic representation of the cell assay format used to
study cell adhesion events in response to cell adhesion inhibitor
candidates (e.g. echistatin).76
Figure 7. Dose-dependent activity of the cell adhesion inhibitor
echistatin. Echistatin’s biological activity is based on tight binding to
α5-integrin and decreases cell adhesion. The binding activity of
echistatin was studied as a function of the inhibition of a cell’s ability
to adhere to the antibody-coated microchannel. Physisorbed
fibronectin was used as reference. Values are reported as the
mean ± standard deviation (SD) and statistical analysis was
performed by single-factor ANOVA for repeated measures followed
by a paired t test. Values of P < 0.05 (one-tailed analysis) were
considered significant.76
chemistry. This eliminates contaminations and guar-
antees a biocompatible process being free of harmful
solvents, initiators, or accelerators. Reactive polymer
coatings can improve the interfacial biocompatibil-
ity of implant surfaces or can be compatible with
complex biological features as they represent a des-
ignable interlayer; stable under the conditions of the
bioassay. Aldehyde, anhydride, or active ester groups
allow for immobilization of proteins; amino or car-
boxylic acid groups may be used to control surface
charges and electro-osmotic flow; while alkyl and fluo-
roalkyl groups may provide hydrophobic interfaces for
electrochromatographic applications. Another critical
feature of reactive coatings with respect to biointerface
engineering is their compatibility with microstructur-
ing by means of µCP or photopatterning. The resulting
patterned surfaces can then be used to control self-
assembly of objects on the nano- and micrometer
scales. CVD-based polymer coatings, and specifically
functionalized poly(p-xylylene)s, represent a fascinat-
ing family of materials with unique features in terms of
synthesis, physical properties, and biomedical applica-
tions.
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